Skip to main content
. 2016 Aug 10;146(9):1816S–1848S. doi: 10.3945/jn.115.229708

TABLE 1.

Historical accounts in the discovery and history of vitamin A research and biomarker development1

Year Discovery
460–325 bc Ancient Egyptians and Greeks cured nightblindness with roasted oxen liver (2)
1860–1863 von Hubbenet associated nightblindness with eye defects and Bitot described conjunctival xerosis by identifying “Bitot’s spots” (reviewed in references 2 and 3)
1861 Schwarz diagnosed nightblindness as a nutritional disease during a naval expedition (reviewed in reference 2)
1904 Mori reported “Hikan” in Japanese children, which responded to cod liver oil and liver (reviewed in reference 2)
1913 McCollum and Davis (4) and Osborne and Mendel (5) discovered “fat-soluble A” in rat feeding studies
1919 Bloch (6) found xerophthalmia in Danish orphans subsisting on a fat-free milk, oatmeal, and barley diet
1919–1920 Steenbock and Gross (7, 8) identified a yellow pigment (β-carotene) that was converted to active colorless vitamin A
1928 Green and Melanby (9) first coined the term “anti-infective” for vitamin A
1930 Moore (10) purified yellow pigment from plants, butter fat, and egg yolk as carotene and showed that it was converted to vitamin A
1931 Karrer et al. (11) isolated and described the chemical structures of retinol and β-carotene (Figure 1)
1931 Green et al. (12) showed that cod liver oil reduces puerperal fever
1932 Ellison (13) reported that vitamin A reduces measles fatality
1935 Wald (14) described “the visual cycle”
1937 Holmes and Corbet (15) isolated and crystallized pure vitamin A from fish liver oil
1947 Isler et al. (16) synthesized retinol
1960 Gopalan et al. (17) drew global attention to endemic vitamin A deficiency in India
1965 Olson and Hayaishi (18) discovered β-carotene 15,15′-dioxygenase as the core enzyme in the conversion of provitamin A carotenoids to vitamin A in the intestine
1966 McLaren et al. (19) published detailed photo accounts of xerophthalmia
1967 Wald (20) received the Nobel Prize in physiology for describing the visual cycle
1974 The International Vitamin A Consultative Group was established (21)
1978 Loerch et al. (22) proposed the principle of the relative-dose-response test in rats
1986 Sommer et al. (23) reported that vitamin A can reduce child mortality in Indonesia followed by recommendations by UNICEF and WHO for the use of high-dose vitamin A supplements (21)
1987–1988 Petkovich et al. (24), Giguere et al. (25), and Benbrooke et al. (26) simultaneously discovered the retinoic acid receptors in cell nuclei
1988 Tanumihardjo and Olson (27) proposed vitamin A2 in a modified-relative-dose-response test
1989 Furr et al. (28) published the use of deuterated retinyl acetate for vitamin A assessment of humans
1990 Beaton et al. (29) summarized 16 studies using vitamin A supplementation, concluding an average childhood mortality reduction of 23%
1992 At the International Conference on Nutrition in Rome, countries committed to preventing vitamin A deficiency (21)
1995 Bioavailability of provitamin A carotenoids in green leafy vegetables challenged by de Pee et al. (30) in Indonesia
1998 Christian et al. (31, 32) in Nepal revealed maternal nightblindness as an indicator of maternal vitamin A deficiency, poor health, and survival
1999 West et al. (33) in Nepal reported that vitamin A or β-carotene supplementation can lower maternal mortality
2001 The Institute of Medicine (34) in the United States revised the β-carotene:retinol bioconversion ratio from 6 μg β-carotene:1 μg retinol to 12:1 and the ratio for other provitamin A carotenoids from 12:1 to 24:1
2003 Thurnham et al. (35) systematically showed the influence of inflammation on serum retinol concentrations
2003 Ramathullah et al. (36) reported from India a 23% reduction in infant mortality by giving newborns a single ∼50,000 IU oral dose of vitamin A, affirming earlier work by Humphrey et al. (37) in Indonesia
2011 The WHO (3842) revised vitamin A supplementation recommendations for women and children on the basis of the current evidence base
2013 Awasthi et al. (43) found a nonsignificant 4% decrease in mortality of Indian children given periodic 200,000-IU supplements
2014 Large randomized, double-blind, placebo-controlled trials in Ghana (44) and Tanzania (45) showed no impact, whereas India showed a 10% reduction (46) in infant mortality after 50,000 IU vitamin A was administered at birth
1

Although comprehensive, the table does not include all of the important discoveries for applications of vitamin A.